ABBV:AbbVie Inc - Stock Price Quote and Dividend Data
LATEST CLOSE STOCK PRICE
$110.50
EXCHANGE
NYSE
SECTOR / SEGMENT / INDUSTRY
Health Care / Pharmaceuticals & Biotechnology / Pharmaceuticals
Trailing 12 Month Dividend Yield4.38%
Projected 10 Year Dividend Yield12.52%
Dividend Yield 5 Year Average4.16%
Dividend Rate$5.20
Dividend Payout Ratio103.00%
Dividend Payout Ratio 5 yr Average88.00%
Dividend Growth Rate 3 yr Average23.86%
Dividend Growth Rate 5 yr Average19.08%
Dividend AllStar™ Ranking
Consecutive Dividend Increases7 Years
Dividend Declaration DateOct. 29, 2020
Dividend Ex DateJan. 14, 2021
Dividend Record DateJan. 15, 2021
Dividend Pay DateFeb. 16, 2021
Dividend Amount Current$1.300
Dividend Amount Previous$1.180
Dividends Paid in the Last 12 Months4
First Dividend Paid2013
52-Week Low/High Stock Price$62.55 - $113.41
Percent Held by Institutions80.36%
Revenue$53,552,000,000
Net Income$9,689,000,000
Cash Flow$5,830,000,000
EPS1.30%
Market Cap$195,084,877,000
PE Ratio to Industry61%
Debt-Equity Ratio570.00%
Debt-Equity to Industry1.16%
Total Return Last 12 Months38.07%
Total Return Last 3 Years14.20%
Total Return Last 5 Years119.37%
Latest Trade DateJan. 25, 2021
AbbVie is a research-based biopharmaceutical company. Co.'s products are focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; as well as other serious health conditions. Co. also has medicines in clinical development across immunology, oncology and neuroscience, with additional targeted investment in cystic fibrosis and women's health.
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryPharmaceuticals
Dividend AllStar™ Ranking
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Oct. 31, 2020DIVIDEND RATE INCREASE: AbbVie Inc (NYSE: ABBV) on 10-31-2020 increased dividend rate > 3% from $4.72 to $5.20
Sep. 11, 2020DIVIDEND ANNOUNCEMENT: AbbVie Inc (NYSE: ABBV) on 09-11-2020 declared a dividend of $1.1800 per share
Jun. 17, 2020DIVIDEND ANNOUNCEMENT: AbbVie Inc (NYSE: ABBV) on 06-17-2020 declared a dividend of $1.1800 per share
Mar. 17, 2020CLOSE PRICE DECREASE: AbbVie Inc (NYSE: ABBV) on 03-17-2020 decreased close price > 10% from $85.37 to $74.27
Feb. 20, 2020DIVIDEND ANNOUNCEMENT: AbbVie Inc (NYSE: ABBV) on 02-20-2020 declared a dividend of $1.1800 per share
Nov. 02, 2019DIVIDEND RATE INCREASE: AbbVie Inc (NYSE: ABBV) on 11-02-2019 increased dividend rate > 3% from $4.28 to $4.72
Nov. 01, 2019DIVIDEND ANNOUNCEMENT: AbbVie Inc (NYSE: ABBV) on 11-01-2019 declared a dividend of $1.1800 per share
Sep. 06, 2019DIVIDEND ANNOUNCEMENT: AbbVie Inc (NYSE: ABBV) on 09-06-2019 declared a dividend of $1.0700 per share
Jun. 26, 2019CLOSE PRICE DECREASE: AbbVie Inc (NYSE: ABBV) on 06-26-2019 decreased close price > 10% from $78.45 to $65.70
Jun. 20, 2019DIVIDEND ANNOUNCEMENT: AbbVie Inc (NYSE: ABBV) on 06-20-2019 declared a dividend of $1.0700 per share
Jan. 26, 2021STOCK PRICE INCREASE: America Great Health (OTCBB: AAGH) on 01-26-2021 increased stock price > 10% from $0.06 to $0.11
Jan. 26, 2021STOCK PRICE DECREASE: Acro Biomedical Co Ltd (OTCBB: ACBM) on 01-26-2021 decreased stock price > 10% from $3.40 to $3.00
Jan. 26, 2021STOCK PRICE INCREASE: Acer Therapeutics Inc (NASDAQ: ACER) on 01-26-2021 increased stock price > 10% from $3.67 to $4.39
Jan. 26, 2021STOCK PRICE INCREASE: AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) on 01-26-2021 increased stock price > 10% from $1.91 to $2.41
Jan. 26, 2021STOCK PRICE DECREASE: Acura Pharmaceuticals Inc (OTCBB: ACUR) on 01-26-2021 decreased stock price > 10% from $0.24 to $0.21
Jan. 26, 2021STOCK PRICE INCREASE: Acusphere Inc (OTCBB: ACUS) on 01-26-2021 increased stock price > 10% from $0.03 to $0.04
Jan. 26, 2021STOCK PRICE DECREASE: ADial Pharmaceuticals Inc (NASDAQ: ADILW) on 01-26-2021 decreased stock price > 10% from $2.23 to $0.74
Jan. 26, 202152 WEEK HIGH: ADial Pharmaceuticals Inc (OTCBB: ADIWW) on 01-26-2021 hit a 52 week high of $1.00
Jan. 26, 2021STOCK PRICE INCREASE: ADial Pharmaceuticals Inc (OTCBB: ADIWW) on 01-26-2021 increased stock price > 10% from $0.10 to $1.00
Jan. 26, 2021STOCK PRICE INCREASE: Akebia Therapeutics Inc (NASDAQ: AKBA) on 01-26-2021 increased stock price > 10% from $3.36 to $3.71